July 2025

Boston Scientific defibrillation leads linked to safety risks | FDA clears wearable heart device | Colchicine & TAVR outcomes ()
World’s first patient receives new-look heart pump | A Class I recall for J&J MedTech | ASE recommendations ()
FDA announces Class I recall | Reaching underserved communities | Artificial heart tech gains key approval | Cannabis & CAD ()
The best heart hospitals in the US | CCTA could make ICA obsolete | FDA clears first EP catheter of its kind | Fear & anxiety ()
ASE president shares his vision | Heartflow files for IPO | Cardiology still leading the way | AI for cardiac amyloidosis ()
CABG or PCI? | New drug candidate for AFib fails | Leadership changes at Edwards Lifesciences | Drinking habits & heart health ()
Week in Review: IVL complications | AI company's IPO | BASILICA before TAVR | A historic heart transplant | CKM syndrome ()
A milestone for new gene therapy | The latest on CKM syndrome | IVL complications | Trump admin takes on ultra-processed foods ()
Q&A: What Medicare covering TriClip means for patients | Surgeons make history with heart reanimation | Radial PCI on the rise ()
Cardiologists may get a pay raise—but concerns remain | Medicare covers TriClip | Heartflow files for IPO | PFA market heats up ()
Care teams could prevent up to 72 million deaths | AI takes risk assessment to another level | New data on SAVR outcomes ()
New tech takes on BASILICA | Company pushes back after FDA warning | Stroke rates after TAVR | Key approvals for Medtronic ()
A key approval for Boston Scientific | PFA market heating up | EP group outlines priorities | AFib ablation & CABG ()
Heartflow files for IPO | First-in-human data on BASILICA before valve-in-valve TAVR | AHA seeks answers on inflammation ()
Week in Review: Surgical devices recalled | CMS proposes pay bump | New ASE guidelines | AI for real-time TAVR guidance ()
A closer look at Trump's health | Catheters recalled due to safety risk | Medtronic expands peripheral portfolio ()
President Trump's diagnosis | World's first robotic surgery of its kind | The power of prevention | A new AI marketplace ()
CGM receivers recalled | The power of prevention | Cannabis linked to significant risks | ‘The start of a paradigm shift’ ()
FDA clears AI software for real-time TAVR guidance | ASE president outlines priorities | Medtronic inks new distribution deal ()
2 big recalls in the world of heart surgery | Polymer valve impresses | Good news for Medtronic | Making history | Salary data ()
CMS proposal includes cardiologist pay bump—but concerns remain | ASNC pushes Congress for change | Vitamin D supplements & CVD ()
New-look heart pump implanted for first time | A historic operation | Managing chronic venous disease | Vaccines make an impact ()
Surgical devices included in multiple Class I recalls | FDA approves finerenone for heart failure | AI-enhanced echo impresses ()
CMS proposes Medicare coverage for renal denervation | New echo guidelines | RBM embraces AI-enabled plaque evaluations ()
Top performing cardiology video interviews this past month ()
FDA clears OTC cuffless BP monitor | Cardiologist killed | New heart pump implanted for first time | Medicare covers TriClip ()
New heart warnings | Medicare covers TriClip | ‘The start of a paradigm shift’ | EP priorities | AMA to help cardiology groups ()
Medicare covers TriClip | First patient receives new heart pump | Cardiology still an AI leader | Myval TAVR valve after 4 years ()
News Alert: Medicare now covers TriClip procedures on a national level ()
Heart valve innovation at a crossroads | Cardiologist questions EARLY TAVR | New-look valve impresses | Real-world TTVR data ()
FDA clears first OTC cuffless blood pressure monitor | Early occlusion after CABG | Statins linked to a new potential benefit ()
Radiation in the cath lab | Catheters recalled | Managing chronic venous disease | Real-world TTVR data | PCI risk assessments ()
Medical malpractice lawsuits & sports cardiology | EP groups share priorities | Important progress for new drug candidate ()
A big FDA approval for Boston Scientific | New-look TAVR valve impresses | Automated PCI risk assessments ()
AI transforms nongated CT, low-quality MRI | FDA sees potential in new blood test | Real-time clot monitoring ()
Radiation in the cath lab | Beloved cardiologist killed in airstrike | A blood test for heart transplant recipients ()
Week in Review: Polymer valve impresses | FDA's new heart pump warning | Innovation at a crossroads | PFA market heats up ()
June's Top Stories: Ranking US heart hospitals | Paralyzed doc fights back | Vaccine updates | Key recalls | Q&A on EARLY TAVR ()
FDA shares warning after patient deaths | Vaccines protect the heart | PFA market heats up ()
News Alert: FDA shares warning about Johnson & Johnson heart pump controllers ()
Cardiologist shares EARLY TAVR concerns | Standardized protocol pays off | Next-day discharge & alternative access ()
Cusp overlap technique boosts TAVR outcomes | Recommendations for managing chronic venous disease | A key approval for Medtronic ()
Heart valve innovation at a crossroads | New data on DCD heart transplants | Private equity firm jumps into vascular health ()